Psycho-Social Well Being Following Stroke (PsychoStroke)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02338869|
Recruitment Status : Completed
First Posted : January 14, 2015
Last Update Posted : March 6, 2019
|Condition or disease||Intervention/treatment||Phase|
|Stroke||Behavioral: Dialogue-based psychosocial rehabilitation||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||322 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Psycho-Social Well Being Following Stroke - A Randomized Controlled Trial|
|Actual Study Start Date :||December 2014|
|Actual Primary Completion Date :||December 2018|
|Actual Study Completion Date :||December 2018|
Experimental: Dialogue-based psychosocial intervention
Participants receive six individual meetings with trained health care professional in additional to usual rehabilitation and care. Dialogues focus on individual psychosocial challenges and needs and provide emotional and informational support to encourage and facilitate coping.
Behavioral: Dialogue-based psychosocial rehabilitation
No Intervention: Usual care Control group
Participants receive usual rehabilitation and care.
- General Health Questionnaire (GHQ 28) [ Time Frame: T2 (6 months poststroke) ]28 item general scale measuring emotional distress. Four subscales (somatic symptoms, anxiety/insomnia, social dysfunction and serious depression
- The Stroke and Aphasia Quality of Life scale (SAQOL-39) [ Time Frame: T2 (6 months poststroke) ]Disease-specific quality of life scale, measures patient's perspective of stroke's impact on 'physical', 'psychosocial' and 'communication' domains.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02338869
|Oslo University hospital|
|Principal Investigator:||Marit Kirkevold, Ed.D||University of Oslo|